Return
DARATUMUMAB-BORTEZOMIB-MELPHALAN-PREDNISONE VS. DARATUMUMAB-LENALIDOMIDE-DEXAMETHASONE IN TRANSPLANT-INELIGIBLE REAL-LIFE PATIENTS WITH MULTIPLE MYELOMA: A SUBANALYSIS OF THE PHASE IV REAL MM TRIAL
C
B
G
M
F
B
C
V
C
P
F
C
P
D
C
S
M
G
C
P
G
C
M
L
S
B
B
L
DOI:.png)
Abstract
En
Journal
IF:
7.9
Papers:
6.4K
Citations:
2.2W
